Search results
Results from the WOW.Com Content Network
MammaPrint is a prognostic and predictive diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other parts of the body. [1] It gives a binary result, high-risk or low-risk classification , and helps physicians determine whether or not a patient will benefit from chemotherapy .
Symphony is a suite of assays that analyze hundreds of genes in an individual breast cancer.The test is marketed by Agendia.The results aid physicians in deciding appropriate treatment for each patient.
MammaPrint has 5 FDA clearances and is the only FDA cleared microarray assay available. To be eligible for the MammaPrint gene expression profile , a breast cancer should have the following characteristics: stage 1 or 2, tumor size less than 5.0 cm, estrogen receptor positive (ER+) or estrogen receptor negative (ER-).
Specialist using "QIAsymphony", an automation platform for molecular diagnostic tests. Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome, and how their cells express their genes as proteins, applying molecular biology to medical testing.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Mammography (also called mastography; DICOM modality: MG) is the process of using low-energy X-rays (usually around 30 kVp) to examine the human breast for diagnosis and screening.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate
James Earl Carter Jr. (October 1, 1924 – December 29, 2024) was an American politician who served as the 39th president of the United States from 1977 to 1981. A member of the Democratic Party, Carter served as the 76th governor of Georgia from 1971 to 1975 and in the Georgia State Senate from 1963 to 1967.